Compugen

-$0.14 (-7.49%) Today
$0.00 (0.00%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Compugen and other ETFs, options, and stocks.

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases.

CEO
Anat Cohen-Dayag
Employees
73
Headquarters
Holon, Tel Aviv
Founded
1993

CGEN Key Statistics

Market cap
137.15M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.10M
High today
$1.82
Low today
$1.69
Open price
$1.80
Volume
946.81K
52 Week high
$9.20
52 Week low
$1.66

CGEN News

Simply Wall StMay 19

Individual investors who hold 49% of Compugen Ltd. gained 12%, institutions profited as well - Simply Wall St

If you want to know who really controls Compugen Ltd. ( ), then you'll have to look at the makeup of its share registry. And the group that holds the biggest pi

CGEN Earnings

-$0.13
-$0.11
-$0.09
-$0.07
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.13 per share
Actual
-$0.11 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure